| Sandoz Pharmaceuticals AG - Quetiapin XR Sandoz 150mg, Retardtabletten |
| 66055 | | 02 | | Quetiapin XR Sandoz 150mg | | Retardtabletten | | N05AH04 | | Quetiapin | | 18.03.2016 | | |
|
| Composition |
| quetiapinum 150 mg ut quetiapini fumaras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, lactosum 42.63 mg, maltosum monohydricum, talcum, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras pro compresso obducto. |
| Packungsbestandteile |
| Comprimés retards | | | | | Principe actif | Concentr. |
|---|
| Quetiapine | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Quetiapine | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Methacrylici | | Überzug | | Ethylis Acrylatis Polymerisatum | | | | Lactosum | 42.63 mg | | | Magnesii Stearas | | | | Maltosum Monohydricum | | | | Talcum | | | | Triethylis Citras pro Compresso Obducto | | |
| |
|
|
